BLAME Inhibitors
BLAME inhibitors are a class of chemical compounds designed to specifically target the BLAME protein, which stands for B-lymphocyte Activator Macrophage Expressed. This protein is a surface receptor primarily expressed on certain immune cells, such as macrophages and B-lymphocytes, and it plays a role in immune regulation and cell signaling. BLAME is involved in mediating cellular interactions that influence immune responses, particularly through its involvement in cell-to-cell communication and receptor signaling. By inhibiting BLAME, researchers can better understand the role this protein plays in modulating immune-related processes, especially those related to the activation and regulation of specific immune cells.
BLAME inhibitors function by binding to the receptor or blocking its ability to interact with its natural ligands, effectively preventing the downstream signaling events that would normally be triggered upon receptor activation. Structurally, these inhibitors are typically small molecules that can precisely target the extracellular or intracellular domains of the BLAME protein, disrupting its normal function. The use of BLAME inhibitors in research is crucial for investigating the specific pathways and cellular responses regulated by this protein. By controlling the activity of BLAME, scientists can explore its contribution to immune system dynamics, particularly how it influences the behavior of macrophages and B-cells in response to external stimuli. These inhibitors are valuable tools for expanding knowledge of immune regulation and cell signaling, as they provide a means to dissect the intricate molecular interactions and pathways involving BLAME in a controlled experimental environment.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 disrupts the interaction between acetylated histones and bromodomain-containing proteins, potentially downregulating the transcriptional machinery necessary for BLAME gene expression in B-cell lineage commitment. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
As a cytidine analogue, 5-Azacytidine incorporates into DNA, leading to the hypomethylation of gene promoters. This could decrease BLAME transcription if its promoter region is susceptible to methylation changes. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A inhibits histone deacetylase activity, which could result in a more open chromatin structure around the BLAME gene, potentially leading to the recruitment of transcriptional repressors that decrease BLAME expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 specifically inhibits MEK1/2, enzymes in the MAPK pathway. The inhibition can lead to reduced activation of downstream ERK, which may be essential for the transcriptional activation of BLAME, thus leading to its reduced expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 acts as a competitive inhibitor of the ATP binding site of PI3K, leading to the downregulation of the PI3K/AKT pathway, which is crucial for the survival and growth of B-cells, potentially resulting in decreased expression of BLAME. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin binds to FKBP12 and together they inhibit mTOR, a key kinase influencing cell growth and proliferation. This inhibition could result in the reduced expression of multiple genes, including BLAME, by diminishing B-cell activation and differentiation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 selectively inhibits JNK, which can lead to the attenuation of AP-1 transcription factor activity. Since AP-1 can drive the expression of various genes, its inhibition may lead to decreased expression of BLAME. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 selectively inhibits p38 MAP kinase, which could lead to the downregulation of cytokine production and reduced activation of transcription factors that are necessary for BLAME gene expression in immune signaling pathways. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082 irreversibly inhibits IκBα phosphorylation, thereby preventing the activation of NF-κB, a transcription factor that could be critical for the expression of BLAME; its inhibition may result in reduced BLAME expression levels. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent and irreversible inhibitor of PI3K, which can lead to the suppression of AKT phosphorylation and activity, potentially leading to the downregulation of BLAME expression as part of the broader inhibition of B-cell receptor signaling. | ||||||